GE HealthCare Technologies Inc. (GEHC) Stock
GEHC Key Statistics
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
CEO: Peter J. Arduini. Company website
GEHC — Frequently Asked Questions
What is the GEHC stock price today?
GE HealthCare Technologies Inc. (GEHC) trades at $64.13, down 0.48% on the day, as of Sep 20, 2026 14:59 UTC.
What is GE HealthCare Technologies Inc.'s market cap?
GE HealthCare Technologies Inc. has a market capitalisation of $28.97B, calculated from the live GEHC share price and shares outstanding.
What is the P/E ratio of GEHC?
GEHC trades at a trailing P/E of 18.59, from earnings per share of $3.45 over the last twelve months.
How much revenue does GE HealthCare Technologies Inc. make?
GE HealthCare Technologies Inc. generated revenue of $20.24B over the trailing twelve months, which puts the stock at 1.43 times sales.
What is the 52-week range for GEHC?
GEHC has traded between $58.75 and $89.77 over the past 52 weeks, and the last price is 28.6% below that high.
Is GE HealthCare Technologies Inc. profitable?
Yes. GE HealthCare Technologies Inc. keeps 7.86% of revenue as net income over the trailing twelve months.
What is the analyst price target for GEHC?
Wall Street analysts rate GEHC Buy, with an average price target of $78.73, 22.8% above the current price.
What sector is GE HealthCare Technologies Inc. in?
GE HealthCare Technologies Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.
Who is the CEO of GE HealthCare Technologies Inc.?
Peter J. Arduini is the chief executive of GE HealthCare Technologies Inc., which employs 54,000 people.
Where can I track GEHC in real time?
QFI Terminal shows GEHC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See GEHC live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open GEHC in Terminal See plans